© 2019 Future Science Group

Unitec House, 2 Albert Place,

London, N3 1QB, UK

Email: info@future-science-group.com
Tel: +44 (0)20 8371 6090

  • LinkedIn - White Circle
  • Facebook - White Circle
  • Twitter - White Circle
  • YouTube - White Circle

News

25 April 2019
Future Science Group begins using Publications Router

Future Science Group (FSG) has begun supplying full-text articles to Jisc’s Publications Router service, enabling onward distribution to institutional repositories.

All journals published by Future Medicine, Future Science and Newlands Press will henceforward send articles to Jisc’s Publications Router, as they are published, meaning that ahead-of-print and subsequently version of record articles will be available in institutional systems in time to meet REF deadlines. This will apply to both open access and subscription content.

“The open access policy landscape is complicated, and at FSG we feel it is important to provide services to help ensure our authors’ needs are met as efficiently possible, so they can spend less time on administration and more time on their research,” explained Francesca Lake, Head of Open Access Publishing at FSG. “Through the use of Publications Router, authors subject to the relevant open access mandates can rest-assured they’ll be compliant, and meet the conditions of the REF. We’re also hopeful this will ease administrative burden at institutions.”

Publications Router will identify participating institutions from the author affiliations, transform the content to meet the needs of the target institution’s system, and deliver it. All content will be accompanied by its metadata, and subscription content will have a 12-month embargo.

About Future Science Group


Founded in 2001, FSG is a progressive publisher focused on breakthrough medical, biotechnological and scientific research. FSG’s portfolio consists of three imprints, Future Medicine, Future Science and Newlands Press, publishing both eBooks and journals. In addition to this core publishing business, FSG develops specialist knowledge networks and content hubs, enabling professionals to easily connect and collaborate with their peers in niche scientific fields.

 

FSG currently publishes 34 peer-reviewed journals as well as 8 knowledge networks and content hubs across a wide range of therapy area and scientific fields. Key journals include Future Microbiology, Future Oncology and the Journal of Comparative Effectiveness Research, alongside sites such as Infectious Diseases Hub, Oncology Central and The Evidence Base.

 

The aim of FSG is to service the advancement of clinical practice and drug research by enhancing the efficiency of communications among clinicians, researchers and decision-makers, and by providing innovative solutions to their information needs. This is achieved through a customer-centric approach, use of new technologies, products that deliver value-for-money and uncompromisingly high standards.